Murata, Nobuhiro
Fukamachi, Daisuke
Matsumoto, Naoya
Tachibana, Eizo
Oiwa, Koji
Matsumoto, Michiaki
Kojima, Toshiaki
Ichikawa, Makoto
Nomoto, Kazumiki
Arima, Ken
Okumura, Yasuo http://orcid.org/0000-0002-2960-4241
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical outcomes for intracoronary imaging strategies at different medical facilities in Japanese patients with coronary artery disease: the SAKURA imaging PCI Registry
https://doi.org/10.1007/s00380-021-01896-x
Article History
Received: 13 February 2021
Accepted: 25 June 2021
First Online: 7 August 2021
Declarations
:
: Dr. Okumura accepted remuneration from Daiichi Sankyo and belongs to the endowed departments of Boston Scientific Japan, Abbott Medical Japan, Japan Lifeline, Medtronic Japan, and Nihon Kohden. Dr. Matsumoto received research funding from Daiichi Sankyo, Otsuka Pharmaceutical, and Sumitomo Dainippon Pharma, and accepted remuneration from Nihon Medi-Physics, FUJIFILM RI Pharma, and Biosensors Interventional Technologies Japan.